We offer a wide range of research products and services for public and privately held life science companies, corporate investors, venture capitalists, and institutional investors.
Full research coverage, including
Valuation Report (comprehensive company analysis, forecasts and valuation)
Research distribution through various channels (e.g. company website, Bloomberg Terminal, Thomson Reuters platform, LinkedIn, targeted email
Investor Call to main shareholders
On a project base, we provide special reports that can be used for business development, M&A activities or to attract new capital, including
Valuation Report (comprehensive company and/or product analyses and valuation)
Investor access to find the right strategic partners or investors through our extensive network
For corporate investors, venture capitalists, and institutional investors, we provide independent assessments and valuations on potential investments,
Interested in coverage of your company by valuationLAB? This can be achieved
typically within 4-6 weeks at a competitive price.